Advertisement

Preliminary Experience With the Human Acellular Vessel: A Descriptive Case Series Detailing Early Use of a Bioengineered Blood Vessel for Arterial Repair

Published:April 06, 2022DOI:https://doi.org/10.1016/j.avsg.2022.03.037

      Background

      An infection-resistant, immediately available conduit for trauma and urgent vascular reconstruction remains a critical need for successful limb salvage. While autologous vein remains the gold standard, vein-limited patients and size mismatch are common issues. The Human Acellular Vessel (HAV) (Humacyte, Inc., Durham, NC) is a bioengineered conduit with off-the-shelf availability and resistance to infection, ideal characteristics for patients with challenging revascularization scenarios. This report describes HAV implantation in patients with complex limb-threatening ischemia and limited conduit options who may have otherwise faced limb loss.

      Methods

      The Food and Drug Administration (FDA) expanded-access program was used to allow urgent implantation of the HAV for arterial reconstruction. Electronic medical records were reviewed with extraction of relevant data including patient demographics, surgical implantation, patency, infectious complications, and mortality.

      Results

      The HAV was implanted in 8 patients requiring vascular reconstruction. Graft or soft tissue infection was present in 2 patients. One patient with severe penetrating pelvic injury had 4 HAV placed to repair bilateral external iliac artery and vein injuries. There was 1 technical failure due to poor outflow, 2 patients died unrelated to HAV use, and 5 lower extremity bypasses maintained patency at an average of 11.4 months (range: 4–20 months). No HAV infectious complications were identified.

      Conclusions

      This report is the first United States series describing early outcomes using the HAV under the FDA expanded-access program for urgent vascular reconstruction. The HAV demonstrates resistance to infection, reliable patency, and offers surgeons an immediate option when confronted with complex revascularization scenarios. Assessment of long-term outcomes will be important for future studies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dua A.
        • Lee C.J.
        Epidemiology of peripheral arterial disease and critical limb ischemia.
        Tech Vasc Interv Radiol. 2016; 19: 91-95
        • Bowlby A.
        • Wallace C.
        The development of British surgery at the Front.
        Br Med J. 1917; 1: 705-721
        • DeBakey M.E.
        • Simeone F.A.
        Battle injuries of the arteries in World War II; an analysis of 2,471 cases.
        Ann Surg. 1946; 123: 534-579
        • Hughes C.
        The primary repair of wounds of major arteries an analysis of experience in Korea in 1953.
        Ann Surg. 1955; 141: 297-303
        • Rich N.M.
        • Baugh J.H.
        • Hughes C.W.
        Acute arterial injuries in Vietnam: 1,000 cases.
        J Trauma. 1970; 10: 359-369
        • White J.M.
        • Stannard A.
        • Burkhardt G.E.
        • et al.
        The epidemiology of vascular injury in the wars in Iraq and Afghanistan.
        Ann Surg. 2011; 253: 1184-1189
        • Vuoncino M.
        • Soo Hoo A.J.
        • Patel J.A.
        • et al.
        Epidemiology of upper extremity vascular injury in Contemporary combat.
        Ann Vasc Surg. 2020; 62: 98-103
        • White P.W.
        • Walker P.F.
        • Bozzay J.D.
        • et al.
        Management and outcomes of wartime cervical carotid artery injury.
        J Trauma Acute Care Surg. 2020; 89: S225-S230
        • Watson J.D.B.
        • Houston R.
        • Morrison J.J.
        • et al.
        A retrospective cohort comparison of expanded polytetrafluorethylene to autologous vein for vascular reconstruction in modern combat casualty care.
        Ann Vasc Surg. 2015; 29: 822-829
        • Morrison J.J.
        • McMahon J.
        • DuBose J.J.
        • et al.
        Clinical implementation of the Humacyte human acellular vessel: Implications for military and civilian trauma care.
        J Trauma Acute Care Surg. 2019; 87: S44-S47
        • Vertrees A.
        • Fox C.J.
        • Quan R.W.
        • et al.
        The use of prosthetic grafts in complex military vascular trauma: a limb salvage strategy for patients with severely limited autologous conduit.
        J Trauma. 2009; 66: 980-983
        • Veith F.J.
        • Gupta S.K.
        • Ascer E.
        • et al.
        Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions.
        J Vasc Surg. 1986; 3: 104-114
        • Taylor L.M.
        • Park T.C.
        • Edwards J.M.
        • et al.
        Acute disruption of polytetrafluoroethylene grafts adjacent to axillary anastomoses: a complication of axillofemoral grafting.
        J Vasc Surg. 1994; 20: 520-528
        • Kirkton R.D.
        • Santiago-Maysonet M.
        • Lawson J.H.
        • et al.
        Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation.
        Sci Transl Med. 2019; 11: eaau6934
        • Lawson J.H.
        • Glickman M.H.
        • Ilzecki M.
        • et al.
        Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.
        Lancet. 2016; 387: 2026-2034
        • Gutowski P.
        • Gage S.M.
        • Guziewicz M.
        • et al.
        Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease.
        J Vasc Surg. 2020; 72: 1247-1258
        • Niklason L.E.
        • Lawson J.H.
        Bioengineered human blood vessels.
        Science. 2020; 370: eaaw8682
        • Almasri J.
        • Adusumalli J.
        • Asi N.
        • et al.
        A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
        J Vasc Surg. 2018; 68: 624-633
        • Kirkton R.D.
        • Prichard H.L.
        • Santiago-Maysonet M.
        • et al.
        Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection.
        J Surg Res. 2018; 221: 143-151
        • Haney L.J.
        • Bae E.
        • Pugh M.J.v.
        • et al.
        Patency of arterial repairs from wartime extremity vascular injuries.
        Trauma Surg Acute Care Open. 2020; 5: e000616
        • Sharrock A.E.
        • Tai N.
        • Perkins Z.
        • et al.
        Management and outcome of 597 wartime penetrating lower extremity arterial injuries from an international military cohort.
        J Vasc Surg. 2019; 70: 224-232
        • Perkins Z.B.
        • Yet B.
        • Glasgow S.
        • et al.
        Long-term, patient-centered outcomes of lower-extremity vascular trauma.
        J Trauma Acute Care Surg. 2018; 85: S104-S111